Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. FDA approves new Baxter drug for hemophilia B
Reuters
Friday, June 28, 2013 - 12:22pm
tags:
FDA, regulatory, Baxter, devices, hemophilia B
Boston Scientific spends $275M on CR Bard business
Yahoo/AP
Friday, June 28, 2013 - 12:20pm
tags:
Boston Scientific, CR Bard, M&A, devices
Biogen investors encouraged by ruling on rival drug, shares jump
Marketwatch
Friday, June 28, 2013 - 12:19pm
tags:
Biogen Idec, Sanofi, Aubagio, Tecfidera, MS, multiple sclerosis
Resverlogix Plunges 93% After Drug Trial Fails
Bloomberg
Friday, June 28, 2013 - 11:51am
tags:
Resverlogix, RVX-208
Novavax Elevating To The Power Of 2
Seeking Alpha
Friday, June 28, 2013 - 11:30am
tags:
Novavax, RSV
Pfizer approves $10 billion share buyback program
Yahoo/AP
Friday, June 28, 2013 - 11:28am
tags:
Pfizer, stock buybacks
Dendreon Surges After Cancer Drug Gets European Backing
Bloomberg
Friday, June 28, 2013 - 10:33am
tags:
prostate cancer, Europe, Dendreon, Provenge
Astellas/Vical Start TransVax Phase III Study
Yahoo/Zacks
Friday, June 28, 2013 - 10:30am
tags:
CMV, cytomegalovirus, TransVax, clinical trials, Astellas, vaccines, Vical
For Allergan Shareholders, Will it Be Dry Eyes or Tears of Joy?
Motley Fool
Friday, June 28, 2013 - 10:26am
tags:
Allergan, Restasis, dry eye disease
Roche inks cancer pact with UK's Immunocore
Pharma Times, UK
Friday, June 28, 2013 - 10:25am
tags:
Roche, Immunocore, cancer
Fish-Oil Pills Lure Drugmakers Even as Benefits Unproven
Bloomberg
Friday, June 28, 2013 - 10:23am
tags:
Amarin, fish oil, AstraZeneca, GSK
Biosimilar versions of Remicade given EU green light
Reuters
Friday, June 28, 2013 - 10:15am
tags:
Remicade, biosimilars, Europe, Celltrion, Remsima, Hospira, Inflectra, rheumatoid arthritis
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Friday, June 28, 2013 - 10:13am
tags:
Novo Nordisk, diabetes, Eli Lilly, GLP-1 agonist, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Victoza
Bayer says FDA requests more data on Xarelto for stent patients
Reuters
Friday, June 28, 2013 - 10:11am
tags:
Bayer, FDA, Xarelto, bloodthinners, stents
FDA approves new Baxter drug for hemophilia B
Reuters
Thursday, June 27, 2013 - 9:01pm
tags:
hemophilia B, Baxter International, Rixubis, FDA
Game may not be over for Royalty' Pharma's bid for Elan
Reuters
Thursday, June 27, 2013 - 8:59pm
tags:
M&A, Elan, Royalty Pharma, Mylan, Allergan, Endo Health Solutions, Forest Labs
SAS And GSK Pull Big Pharma Into Big Data Collaboration
Forbes
Thursday, June 27, 2013 - 8:57pm
tags:
SAS, GSK, data
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thursday, June 27, 2013 - 8:55pm
tags:
Eli Lilly, diabetes, dulaglutide, JNJ, Merck, Novo Nordisk, Bristol-Myers Squibb
IPO Preview: Prosensa Holding B.V.
Seeking Alpha
Thursday, June 27, 2013 - 8:53pm
tags:
IPOs, Prosensa, GSK
Novel Heart Failure Drug From Novartis Gains 'Breakthrough Therapy' Designation From FDA
Forbes
Thursday, June 27, 2013 - 8:52pm
tags:
breakthrough therapies, heart failure, Novatis, serelaxin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.